Lindbrook Capital, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,751
+6.3%
132
+22.2%
0.00%
Q2 2023$2,587
+49.5%
108
+17.4%
0.00%
Q1 2023$1,731
+18.2%
920.0%0.00%
Q4 2022$1,465
-75.6%
92
-76.8%
0.00%
-100.0%
Q3 2022$6,000
+200.0%
396
+204.6%
0.00%
Q2 2022$2,000
-50.0%
130
-22.2%
0.00%
-100.0%
Q1 2022$4,000
+100.0%
167
+68.7%
0.00%
Q4 2021$2,0000.0%990.0%0.00%
-100.0%
Q3 2021$2,0000.0%99
+52.3%
0.00%
Q1 2021$2,000
+100.0%
65
+441.7%
0.00%
Q4 2020$1,000120.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 432,317$11,154,0004.70%
Baker Brothers Advisors 41,910,704$1,081,296,0004.69%
Palo Alto Investors LP 2,337,877$60,317,0003.44%
Birchview Capital, LP 177,000$4,567,0002.71%
Longitude (Cayman) Ltd. 188,000$4,850,0001.86%
GREAT POINT PARTNERS LLC 311,217$8,029,0001.66%
Avoro Capital Advisors LLC 2,500,000$64,500,0001.11%
PFM Health Sciences, LP 1,302,129$33,595,0001.03%
HealthCor Management, L.P. 900,490$23,233,0000.82%
Eversept Partners, LP 420,000$10,836,0000.82%
View complete list of ACADIA PHARMACEUTICALS INC shareholders